Finally, there are indications that glucocorticoid receptor induction leads to a decreased expression and inhibition of the activity of MAP kinases and other transcription factors such as NF-κB, p53 and STAT1, associating the glucocorticoid receptor with tumor suppression in the prostate [63,74,91]. Here, NR3C1 is linked to neoplasm.